Medical Oncologist
Resistance & next lines
Should You Change Hospitals — After Cancer Progression?
Progression is one of the hardest words in oncology. This page explains why resistance happens, what realistic next steps look like, and when it genuinely makes sense to seek a new centre rather than continuing where you are.
Medically reviewed by Dr. Bharati Devi Gorantla, Medical Oncologist, MBBS · MD · DM (Adyar, Chennai) · ECMO · MRCP SCE (UK) · Last reviewed August 2026
- Resistance is biology, not negligence — Cancer cells mutate over time. A treatment that worked initially can stop working as resistant cells take over — regardless of the quality of your care.
- Next-line options usually exist — Most cancer types have second or third-line treatments. Progression closes one door; it rarely closes all of them.
- A second opinion is always legitimate — Asking for another view does not mean leaving your team. Many patients seek a second opinion and return to their original centre for treatment.
- Moving centres takes time — Collecting records, being reassessed, and starting at a new hospital takes several weeks. That delay is worth it only when the new centre offers something your current team cannot.
17+
Cancer Specialists
on Panel
on Panel
96.9%
Breast Cancer
Survival Rate*
Survival Rate*
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
Progression usually means your cancer has developed resistance to the current treatment, not that your hospital has made an error. In most cases, your current team can offer a next-line treatment. A second opinion or new centre is worth seeking when your team has no further options, or when a specific trial is only open elsewhere.
Why did your cancer stop responding to treatment?
Cancer cells can change over time. When treatment works, it kills most of the cancer cells — but a small number may carry a mutation that makes them harder to destroy. Those cells survive, multiply, and eventually become the dominant population.
This is called acquired resistance. It happens across virtually every cancer type and is a property of cancer biology, not a consequence of inadequate care.
Understanding this matters because it changes the question. After progression, the right question is not 'who failed?' but 'what comes next?'
What are the treatment options after progression?
For most cancer types, a second-line or later-line treatment exists — a drug or combination that works through a different mechanism and can still affect cells that resisted the first treatment.
Your oncologist will look at what you have already had, what repeat testing shows now, and what your current health allows. Clinical trials are worth asking about at this stage — they are designed specifically for patients who have already progressed on standard therapy.
In some situations, the goal of treatment changes from controlling the cancer to controlling symptoms. That conversation, when it comes, should happen directly and clearly — and it is different from saying nothing more can be done.
When seeking a second opinion or a new centre genuinely makes sense
- Your team says no further treatment options are available — a second opinion confirms this or finds one you have not been offered.
- Your cancer is rare and your current centre does not see many cases like yours.
- A clinical trial you want to explore is only available at another centre.
- Your case has not been reviewed by a multidisciplinary tumour board.
- You want reassurance that the plan is the right one — that alone is a legitimate reason to seek another view.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Get a straight answer from a specialist
45 minutes, your reports reviewed, your questions answered in plain language.
What to ask your current team before deciding to move
Before making any decision, ask your oncologist directly: what next-line therapy is being considered, what it is expected to achieve, and whether any clinical trial applies to you. A clear answer to those three questions is reasonable to expect.
If you want a second opinion, say so directly. You can seek one without leaving your current team — many patients have a review with a second oncologist and return to their original centre for treatment.
Moving hospitals takes time. Collecting records, transferring care, and being reassessed can take several weeks. That delay is worth it only when the new centre genuinely offers something your current team cannot.
Terms you will hear after progression
- Progression
- When scans or tests show the cancer has grown or spread despite treatment. It means the current treatment has stopped working — not that all treatment is finished.
- Next-line therapy
- A second or later-line treatment tried after the first-line option stops working. Each line uses a different mechanism to target the cancer.
- Acquired resistance
- When a cancer that initially responded to a treatment develops changes — usually mutations — that make it no longer affected by that drug.
- Clinical trial
- A research study testing a treatment not yet in standard use, or comparing treatment approaches. Later-line trials are designed specifically for patients who have already progressed on standard therapy.
- Second opinion
- A review of your diagnosis, test results, and treatment plan by a different oncologist. Seeking one does not mean leaving your current team.
- Best supportive care
- Treatment focused on managing symptoms — pain, nausea, fatigue — rather than controlling the cancer. It is active, expert care, and it is not the withdrawal of treatment.
Questions families ask after a progression scan
Does progression mean the cancer is no longer treatable?
Progression means the current treatment stopped controlling the cancer — it does not automatically mean the cancer is untreatable. Most cancer types have second-line and later-line options. Whether those apply to you depends on your specific cancer type, which treatments you have already had, what your current test results show, and your general fitness. Ask your oncologist directly: what is the next treatment option and what is it expected to achieve? That question deserves a specific answer, not a general one.
Will a bigger hospital in another city give a better chance?
A larger centre helps when it sees high volumes of a rare cancer, has access to a trial not open at your current centre, or has subspecialty expertise in a specific technique. For most cancer types, the next-line standard treatment is the same across accredited oncology centres. Moving does not itself improve outcomes — access to the right next-line therapy does. Ask what the bigger centre offers that your current team cannot, before deciding the disruption and delay are worth it.
Is it too late to join a clinical trial after progression?
Clinical trials for later-line treatment specifically recruit patients who have already progressed on standard therapy. It is not too late to ask. Start by asking your oncologist whether a relevant trial exists, and ask them to check the Clinical Trials Registry of India for open studies in your cancer type. Entry criteria vary — some require a specific mutation result or a minimum gap since your last treatment. Do not rule out a trial without first checking what is open and whether you meet the criteria.
Can we seek a second opinion without pausing treatment?
Seeking a second opinion does not automatically pause your treatment. Many patients continue their current treatment while waiting for the second opinion appointment, unless their oncologist advises otherwise. Ask your current team directly: can I continue treatment while gathering records and waiting for the appointment? Planning the two in parallel avoids unnecessary delay. The reviewing oncologist will need your original pathology reports and imaging, not just a summary letter.
How do we get our records transferred to a new centre?
Ask your hospital's medical records department for a complete set: pathology reports, imaging CDs with the original images and their reports, all treatment summaries, discharge records, and your most recent blood results. Keep your own copy in addition to sending one to the new centre. The reviewing oncologist will need to see the original pathology, not just a summary — request the full reports rather than a brief referral letter.
Explore 39 more Monitoring, Resistance & Long-Term Response topics
Resistance, Progression & Next Lines
- Being Told 'There Are No More Options': Is That Really True?
- Brain Metastases on Targeted Therapy: Does Your Drug Reach the Brain?
- Can You Continue the Same Drug After Progression?
- Combination Therapy to Overcome Resistance
- Do You Need Another Biopsy When the Cancer Progresses?
- Histologic Transformation: When Lung Cancer Changes Type
- How to Emotionally Process a Progression Scan
- Leptomeningeal Disease: Symptoms, Diagnosis and Treatment
- Life After ALK Inhibitor Resistance: Sequencing Your Options
- MET Amplification and Other Bypass Resistance Mechanisms
- Oligoprogression: When Only One or Two Spots Grow
- Primary vs Acquired Resistance: Two Very Different Problems
- Should You Change Hospitals After Progression?
- What Happens After Osimertinib Stops Working?
- What Is Sequencing and Why the Order of Drugs Matters
- Why Does Targeted Therapy Stop Working? The Biology of Resistance
Long-Term Response, Stopping & Survivorship
- Am I Still a Cancer Patient? Identity After Long-Term Response
- Bone Health, Heart Health and Late Effects to Monitor
- Can You Ever Stop Targeted Therapy If the Cancer Is Gone?
- Drug Holidays: Are Planned Breaks Safe?
- Follow-Up Schedule After Stopping Targeted Therapy
- How Long Do You Have to Stay on Targeted Therapy?
- Long-Term Effects of Taking a TKI for 5 or 10 Years
- Restarting Treatment After a Break
- Treatment-Free Remission in CML: Who Can Stop Their TKI?
- Your Survivorship Care Plan: What Should Be In It
Monitoring, Scans & Response Assessment
- Are Tumour Markers Reliable on Targeted Therapy?
- Complete Response, Partial Response, Stable Disease: What Each Means
- Do I Need Regular Brain MRIs on Targeted Therapy?
- How Doctors Measure Whether Targeted Therapy Is Working
- How Often Will I Need Scans on Targeted Therapy?
- How to Read a CT or PET Scan Report Without Panicking
- Is 'Stable Disease' Good News or Bad News?
- Scanxiety: How to Get Through the Wait for Scan Results
- Tumour Flare and Pseudoprogression: When Growth Isn't Really Growth
- Understanding PFS, OS and Median Survival Without Losing Hope
- What Happens at a Follow-Up Visit: A Walk-Through
- Which Blood Tests Are Repeated Every Month and Why
- ctDNA Monitoring: Can a Blood Test Predict Progression Early?
Next step
Still not sure what applies to you?
Send your reports across and a senior medical oncologist will go through what they mean, what is known, and what the options actually are.
Common questions
Frequently asked questions
Does progression mean the treatment has completely failed?
Progression means the current treatment stopped controlling the cancer — not that all options are gone. For most cancer types, second-line and later-line treatments exist. What is available next depends on your cancer type, what you have already received, and what your current health allows. Ask your oncologist to take you through the next-line options at your next appointment and to explain what each is intended to achieve.
Will my doctor be upset if I ask for a second opinion?
A good oncologist expects patients to seek second opinions after progression — it is a reasonable step and most welcome it. The simplest approach is to say directly that you would like another oncologist to review the plan before you decide. You can seek a second opinion and return to your current team for treatment if you choose. Bring all your original records to the appointment so the second oncologist can give a proper assessment rather than a general impression.
Is changing hospitals the same as giving up on treatment?
No. Moving to a different centre is a decision about where to receive treatment, not whether to receive it. People change centres after progression for several reasons — a trial is only open elsewhere, a second opinion points to a different plan, or practical factors like distance. If both teams recommend the same next step, you can choose either centre based on what works for you. If they differ, that difference is valuable information in itself.
How long does it take to start a new treatment after progression?
The time depends on what the next treatment requires. Some next-line treatments can start quickly if the treatment is available and you are fit enough. Others need repeat biopsy and biomarker testing, which adds time before the next treatment can begin. Clinical trials have their own screening process and can take longer still. Ask your team for the specific steps and an expected timeline for the plan they are recommending, so you have a clear date rather than an open-ended wait.
What does CION do when a patient has progressed?
At CION, progression triggers a structured review — what has been tried, what your current imaging and test results show, and what next-line options apply to your cancer type. This may include repeat biopsy, updated staging scans coordinated with partner imaging centres, or referral for a specialist second opinion. Systemic treatment for next-line care continues as day care at CION centres where that is appropriate for the regimen. Ask your treating oncologist to walk you through the next-line plan at your next appointment.
What is best supportive care — is it the same as giving up?
Best supportive care is active, expert treatment focused on managing symptoms — pain, breathlessness, fatigue, nausea — rather than trying to shrink the cancer. It is not giving up. For some patients it is the primary approach; for others it runs alongside cancer-directed treatment. It is distinct from stopping all care, and it often significantly improves quality of life. If best supportive care is mentioned at your appointment, ask your team to explain specifically what that would mean for you.